Price To Earnings Ratio 37.35 | Sector PE 69.47 |
PB Ratio 6.52 | Sector PB 9.32 |
EPS 150.21 | Dividend Yield 0.81 |
Today's Volume 233.978 K | 5 Day Avg. Volume 185.831 K |
PEG Ratio 0.45 | Market Cap. ₹ 67,460.00 Cr. |
Time | ALKEM | VS | Industry |
---|---|---|---|
1 Day | 1.41% | 0.19% | |
1 Week | 4.37% | 3.31% | |
1 Month | -1.38% | 0.92% | |
6 Months | 11.47% | 22.41% | |
1 Year | 18.48% | 48.28% |
Period (Days) | SMA | Indication |
---|---|---|
10 | 5493.41 | Bullish |
20 | 5508.94 | Bullish |
30 | 5605.35 | Bullish |
50 | 5785.08 | Bearish |
100 | 5772.14 | Bearish |
200 | 5550.49 | Bullish |
Annual | FY 2024 | FY 2023 | FY 2022 | ||||
---|---|---|---|---|---|---|---|
Operating Activities | 1948.07 | 1682.50 | 1111.02 | ||||
Investing Activities | -1008.50 | 112.84 | -1435.13 | ||||
Financing Activities | -1145.01 | -1760.82 | 379.57 | ||||
Net Cash Flow | -205.44 | 34.52 | 55.46 |
All Figures in ₹ Cr., unless mentioned otherwise
Name | 1D (%) | 1W (%) | 1M (%) | 6M (%) | 1Y (%) |
---|---|---|---|---|---|
Alkem Laboratories | 1.41 | 4.37 | -1.38 | 11.47 | 18.48 |
Alembic | 1.66 | 6.55 | 4.98 | 2.76 | 2.76 |
Aurobindo Pharma | 0.39 | 3.15 | -9.87 | -7.14 | 16.99 |
Fortis Healthcare | 2.25 | 10.82 | 13.14 | 42.21 | 81.43 |
Ajanta Pharmaceuticals | 0.27 | -1.65 | -3.39 | 19 | 46.25 |
Alkem Laboratories Limited is an Indian company engaged in pharmaceutical business worldwide. The company's field of activity is the development, production and sale of pharmaceutical and nutritional products. The company offers its products in several therapeutic areas such as infectious diseases, dermatology, diabetes, cardiology, gastroenterology, osteoporosis, rheumatology, central nervous system and (CNS), oncology, urology, gynecology and vitamins, minerals and nutrition. Its product portfolio includes Rx Products, Alkem Generics and OTC Products. The company's product range includes brands such as Clavam, Pan, Pan-D, Taxim-O, A To Z NS, Xone, Taxim, Gemcal, Pipzo and Ondem. The company operates through the pharmaceutical segment. It has around 21 manufacturing facilities at various locations in India and the United States. The company has approximately 800 brands and operates in 40 countries.